Year |
Citation |
Score |
2012 |
Il'yasova D, Wang F, Spasojevic I, Base K, D'Agostino RB, Wagenknecht LE. Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI. Obesity (Silver Spring, Md.). 20: 2147-50. PMID 22836686 DOI: 10.1038/Oby.2012.170 |
0.381 |
|
2012 |
Siamakpour-Reihani S, Scarbrough PM, Wang F, Spasojevic I, Base K, Sedjo R, D'Agostino RB, Il'yasova D. Systemic markers of oxidative status and colorectal adenomatous polyps. Annals of Epidemiology. 22: 587-91. PMID 22695388 DOI: 10.1016/J.Annepidem.2012.05.001 |
0.318 |
|
2012 |
Il'yasova D, Spasojevic I, Base K, Zhang H, Wang F, Young SP, Millington DS, D'Agostino RB, Wagenknecht LE. Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes. Diabetes Care. 35: 173-4. PMID 22100959 DOI: 10.2337/Dc11-1502 |
0.345 |
|
2012 |
Il'yasova D, Wang F, Spasojevic I, Base K, D'Agostino RB, Wagenknecht LE. Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort. Obesity (Silver Spring, Md.). 20: 1915-21. PMID 21959342 DOI: 10.1038/Oby.2011.292 |
0.358 |
|
2010 |
Il'yasova D, Reihani S, Spasojevic I, Base K, Tolun A, Wang F, Young S, Millington D, D Agostino RB. Association between Systemic Markers of Oxidative Status and the Risk of Colorectal Adenoma Polyps Free Radical Biology and Medicine. 49: S68. DOI: 10.1016/J.Freeradbiomed.2010.10.166 |
0.342 |
|
2010 |
Il'yasova D, Spasojevic I, Base K, Tolun A, Zhang H, Wang F, Young S, Millington D, D'Agostino RB, Wagenknecht LE. Systemic Markers of Oxidative Status and the Risk of Type 2 Diabetes Free Radical Biology and Medicine. 49: S38. DOI: 10.1016/J.Freeradbiomed.2010.10.076 |
0.325 |
|
Show low-probability matches. |